Literature DB >> 31526152

Generating timely molecular diagnostic test results: workflow comparison of the cobas® 6800/8800 to Panther.

Gudrun Aretzweiler1, Susanne Leuchter1, Christian O Simon2, Ed Marins2, Andre Frontzek1.   

Abstract

Background: Molecular diagnostic tests for HBV, HCV and HIV-1 and other pathogens are widely used for clinical management. Practical issues related to workflow and labor requirements need to be characterized to inform selection of the most appropriate system. Research design and methods: We compared the workflow of two high-throughput systems: cobas 6800 (Roche) and Panther (Hologic), using average mid-size laboratory test volumes for five different assays (HIV-1, HBV, HCV, HPV or TV, and CT/NG).
Results: Set-up time, time to first results, time to last results, and total hands-on time for cobas 6800 was 0.40, 2.47, 7.12, and 0.98 hours, respectively; on the Panther system, these times were 0.75, 2.7, 9.1, and 1.48 hours. Fifty-seven samples had results available at the first time point on cobas 6800 compared to 5 samples on the Panther system. The Panther system required more manual steps including several with potential risks of contamination or error. The number of reagents items required was 5 for cobas 6800 and 40 for the Panther system. Conclusions: Both systems provided a high level of automation. The cobas 6800 platform had shorter start up, time to first result, time to last result and hands-on times than the Panther system.

Entities:  

Keywords:  Cobas; PCR; Panther; molecular diagnostics; workflow

Mesh:

Substances:

Year:  2019        PMID: 31526152     DOI: 10.1080/14737159.2019.1665999

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  4 in total

Review 1.  An Overview of SARS-CoV-2 Molecular Diagnostics in Europe.

Authors:  Emma Davies; Hamzah Z Farooq; Benjamin Brown; Peter Tilston; Ashley McEwan; Andrew Birtles; Robert William O'Hara; Shazaad Ahmad; Nicholas Machin; Louise Hesketh; Malcolm Guiver
Journal:  Clin Lab Med       Date:  2022-03-08       Impact factor: 2.172

2.  Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting.

Authors:  Dominik Nörz; Nicole Fischer; Alexander Schultze; Stefan Kluge; Ulrich Mayer-Runge; Martin Aepfelbacher; Susanne Pfefferle; Marc Lütgehetmann
Journal:  J Clin Virol       Date:  2020-04-28       Impact factor: 3.168

3.  Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program.

Authors:  Ditte Møller Ejegod; Helle Pedersen; Birgitte Tønnes Pedersen; Christine Monceyron Jonassen; Agnes Kathrine Lie; Laila Solhaug Hulleberg; Marc Arbyn; Jesper Bonde
Journal:  Am J Clin Pathol       Date:  2022-03-03       Impact factor: 2.493

4.  Performance Evaluation of the Aptima Assays in Comparison with the cobas 6800 Assays for the Detection of HIV-1, HBV, and HCV in Clinical Samples.

Authors:  Younhee Park; Juhye Roh; Sinyoung Kim
Journal:  Ann Lab Med       Date:  2022-07-01       Impact factor: 4.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.